Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
在接受二代酪氨酸激酶抑制剂 (TKI) 治疗后,慢性期慢性粒细胞白血病 (CML) 患者逐步增加博舒替尼剂量:博舒替尼剂量优化 (BODO) 研究的结果
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-023-05394-0
Isfort, Susanne; Manz, Kirsi; Teichmann, Lino L; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus; Wolf, Dominik; Brümmendorf, Tim H